Rennova Health's Technology Solutions Subsidiary Medical Mime Launches Version 3 of Its Flagship Electronic Health Records Product

Download as PDF

WEST PALM BEACH, FL -- (Marketwired) -- 06/29/17 -- Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Medical Mime, Inc. has launched version 3 of its flagship Electronic Health Records (EHR) product M2Select.

Medical Mime, Inc. is owned by Rennova's IT solutions division and subsidiary, Health Technology Solutions, Inc. (HTS). Medical Mime's mission is to develop and deliver exceptionally intuitive, simplified and effective healthcare IT solutions that meet the unique needs of medical practitioners.

M2Select is an EHR tailored for the addiction treatment industry. The new features launched in version 3 of its M2Select product are:

  • Custom Forms Modernization - A new way to create and use custom forms for many client workflows (Intake, Verification of benefits, American Society of Addiction Medicine forms, Group Session, Case Management, Treatment Plans, etc.)
  • Treatment Plan Editor - Ability to use library of DSM-V treatment plans, customize them, or even build specific plans from scratch (symptoms, goals, objectives, interventions) for individual care and treatment.
  • iPad Update - More functionality and critical bug fixes; full use of above custom forms and treatment plans. More consistency with desktop / browser version. Leverage of iPad specific capabilities (client photos, touch-based signature, speech recognition).
  • UI Refresh - Clean and modern looking new UI with fresh theme, colors, and new logo across all areas of product (browser, iPad, website, documentation).

"This is the single biggest release we have done in the last two years. It represents the culmination of many incremental feature improvements suggested by our customers as well as quality and design improvements," said Dr. Thomas Laussermair, VP IT Engineering. "Our rapid pace of eight minor releases over the last 12 months is a sign of a healthy product pipeline. Thanks to ongoing investments in the underlying process, quality assurance, and automation we are now able to deliver frequent updates to a product of such power and flexibility while at the same time keeping it secure, easy to use and consistent across different endpoints and devices. First indications are that our customers love it!"

"We continue to invest in building quality software solutions that will ensure a long term relationship with our customers," said Seamus Lagan, CEO of Rennova, "We believe that our focus on quality, ease of use and integration will allow us to increase our customer bases with the services we provide and grow our recurring revenue stream from this division of our business."

About Rennova Health, Inc.
 Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.

Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contacts:
Rennova Health
Sebastien Sainsbury
561-666-9818
ssainsbury@rennovahealth.com

Investors
LHA
Kim Golodetz
212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss
310-691-7100
Bvoss@lhai.com

Source: Rennova Health, Inc.

Released June 29, 2017